CHICAGO (Reuters) - The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on NeuroPace (NPCE – Research Report) today and set a price target of $20.00. The ...

The analyst who wrote this piece owns shares of Semler Scientific (SMLR). Medical-devices maker Semler Scientific (SMLR) ...

Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...